A detailed history of Met Life Investment Management, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 29,422 shares of AXNX stock, worth $2.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,422
Previous 29,422 -0.0%
Holding current value
$2.09 Million
Previous $1.98 Million 3.59%
% of portfolio
0.01%
Previous 0.01%

Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$66.47 - $69.65 $255,311 - $267,525
3,841 Added 15.02%
29,422 $1.98 Million
Q1 2024

May 14, 2024

BUY
$56.67 - $69.36 $1.45 Million - $1.77 Million
25,581 New
25,581 $1.76 Million
Q3 2023

May 09, 2024

BUY
$48.64 - $62.51 $10,895 - $14,002
224 Added 0.86%
26,195 $1.47 Million
Q2 2023

Apr 29, 2024

BUY
$47.99 - $60.21 $1.26 Million - $1.58 Million
26,195 New
26,195 $1.32 Million
Q2 2023

Aug 10, 2023

BUY
$47.99 - $60.21 $10,749 - $13,487
224 Added 0.86%
26,195 $1.32 Million
Q1 2023

May 09, 2024

BUY
$52.6 - $67.34 $1.37 Million - $1.75 Million
25,971 New
25,971 $1.42 Billion
Q3 2022

May 10, 2024

BUY
$57.96 - $78.12 $71,522 - $96,400
1,234 Added 4.99%
25,971 $1.83 Million
Q3 2022

Mar 22, 2023

BUY
$57.96 - $78.12 $71,522 - $96,400
1,234 Added 4.99%
25,971 $1.83 Million
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $71,522 - $96,400
1,234 Added 4.99%
25,971 $1.83 Million
Q2 2022

Jun 20, 2023

SELL
$39.5 - $64.42 $48,743 - $79,494
-1,234 Reduced 4.75%
24,737 $1.4 Million
Q1 2022

May 10, 2024

BUY
$43.74 - $62.76 $1.08 Million - $1.55 Million
24,737 New
24,737 $1.55 Million
Q1 2022

Jun 20, 2023

SELL
$43.74 - $62.76 $53,975 - $77,445
-1,234 Reduced 4.75%
24,737 $1.55 Million
Q1 2022

Mar 22, 2023

BUY
$43.74 - $62.76 $384,124 - $551,158
8,782 Added 55.04%
24,737 $1.55 Million
Q1 2022

May 12, 2022

BUY
$43.74 - $62.76 $384,124 - $551,158
8,782 Added 55.04%
24,737 $1.55 Million
Q4 2021

Jun 21, 2023

SELL
$50.01 - $73.35 $500,900 - $734,673
-10,016 Reduced 38.57%
15,955 $893,000
Q3 2021

May 17, 2024

BUY
$59.21 - $78.66 $55,775 - $74,097
942 Added 6.27%
15,955 $1.04 Million
Q3 2021

Jun 21, 2023

SELL
$59.21 - $78.66 $593,047 - $787,858
-10,016 Reduced 38.57%
15,955 $1.04 Million
Q3 2021

Mar 22, 2023

BUY
$59.21 - $78.66 $55,775 - $74,097
942 Added 6.27%
15,955 $1.04 Million
Q3 2021

Nov 15, 2021

BUY
$59.21 - $78.66 $55,775 - $74,097
942 Added 6.27%
15,955 $1.04 Million
Q2 2021

May 17, 2024

BUY
$51.39 - $66.9 $173,030 - $225,252
3,367 Added 28.91%
15,013 $951,000
Q2 2021

Jun 21, 2023

SELL
$51.39 - $66.9 $563,131 - $733,090
-10,958 Reduced 42.19%
15,013 $951,000
Q2 2021

Mar 22, 2023

BUY
$51.39 - $66.9 $173,030 - $225,252
3,367 Added 28.91%
15,013 $951,000
Q2 2021

Aug 16, 2021

BUY
$51.39 - $66.9 $173,030 - $225,252
3,367 Added 28.91%
15,013 $952,000
Q1 2021

May 17, 2024

SELL
$49.14 - $59.89 $684,765 - $834,567
-13,935 Reduced 54.47%
11,646 $697,000
Q1 2021

Jun 26, 2023

SELL
$49.14 - $59.89 $703,930 - $857,924
-14,325 Reduced 55.16%
11,646 $697 Million
Q1 2021

Mar 22, 2023

SELL
$49.14 - $59.89 $105,405 - $128,464
-2,145 Reduced 15.55%
11,646 $697,000
Q1 2021

May 14, 2021

SELL
$49.14 - $59.89 $105,405 - $128,464
-2,145 Reduced 15.55%
11,646 $697,000
Q4 2020

Jun 22, 2023

SELL
$42.19 - $51.5 $513,874 - $627,270
-12,180 Reduced 46.9%
13,791 $688,000
Q3 2020

Jun 26, 2023

SELL
$35.33 - $51.04 $430,319 - $621,667
-12,180 Reduced 46.9%
13,791 $703,000
Q2 2020

May 24, 2024

SELL
$22.91 - $39.83 $270,108 - $469,595
-11,790 Reduced 46.09%
13,791 $484 Million
Q2 2020

Jun 26, 2023

SELL
$22.91 - $39.83 $279,043 - $485,129
-12,180 Reduced 46.9%
13,791 $484,000
Q2 2020

Mar 22, 2023

BUY
$22.91 - $39.83 $144,859 - $251,845
6,323 Added 84.67%
13,791 $484,000
Q2 2020

Aug 14, 2020

BUY
$22.91 - $39.83 $144,859 - $251,845
6,323 Added 84.67%
13,791 $484,000
Q1 2020

Jul 12, 2023

SELL
$16.44 - $37.73 $304,189 - $698,118
-18,503 Reduced 71.24%
7,468 $189,000
Q4 2019

Jul 12, 2023

SELL
$19.57 - $28.96 $362,103 - $535,846
-18,503 Reduced 71.24%
7,468 $206,000
Q3 2019

Jul 12, 2023

SELL
$26.92 - $42.41 $498,100 - $784,712
-18,503 Reduced 71.24%
7,468 $201,000
Q3 2019

Mar 22, 2023

SELL
$26.92 - $42.41 $498,100 - $784,712
-18,503 Reduced 71.24%
7,468 $201,000
Q3 2019

Nov 14, 2019

BUY
$26.92 - $42.41 $201,038 - $316,717
7,468 New
7,468 $201,000
Q2 2019

Jul 12, 2023

SELL
$18.54 - $40.97 $343,045 - $758,067
-18,503 Reduced 71.24%
7,468 $306 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.